Could A2 MILK COMPANY LTD (OTCMKTS:ACOPF) Change Direction After Less Shorts?

December 6, 2017 - By Peter Erickson

The stock of A2 MILK COMPANY LTD (OTCMKTS:ACOPF) registered a decrease of 4.14% in short interest. ACOPF’s total short interest was 941,900 shares in December as published by FINRA. Its down 4.14% from 982,600 shares, reported previously. With 30,300 shares average volume, it will take short sellers 31 days to cover their ACOPF’s short positions.

The stock decreased 1.15% or $0.065 during the last trading session, reaching $5.585. About 1,045 shares traded. The a2 Milk Company Limited (OTCMKTS:ACOPF) has 0.00% since December 6, 2016 and is . It has underperformed by 16.70% the S&P500.

The a2 Milk Company Limited, together with its subsidiaries, commercializes a2MC brand milk and related products. The company has market cap of $4.31 billion. It offers branded dairy nutritional products that are A1 protein-free. It has a 66.49 P/E ratio. The companyÂ’s products include fresh milk, infant formula, whole and skim milk powders, and other dairy products.

More notable recent The a2 Milk Company Limited (OTCMKTS:ACOPF) news were published by: which released: “Top broker says a2 Milk Company Ltd (Australia) shares are worth $7.25” on October 03, 2017, also with their article: “Why a2 Milk Company Ltd (Australia) just keeps growing” published on August 22, 2017, published: “The a2 Milk Company Ltd (Australia) share price is falling before its November …” on November 03, 2017. More interesting news about The a2 Milk Company Limited (OTCMKTS:ACOPF) were released by: and their article: “Here are 3 reasons to buy a2 Milk Company Ltd (Australia) shares” published on March 14, 2017 as well as‘s news article titled: “Can the A2 Milk Company Ltd share price hit $6?” with publication date: August 28, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: